Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 8/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | POLB | P06746 | 10/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.63 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 12/20 | 0.61 |
| ▸ | CTDSP1 | Q9GZU7 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 2/20 | 0.59 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.58 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL64694 | 1.00 | L3MBTL1 (0.68) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL3506542 | 0.88 | POLB (0.66) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL873279 | 0.88 | POLB (0.66) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL873278 | 0.88 | POLB (0.66) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL7142741 | 0.87 | ALDH1A1 (0.67) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL7142739 | 0.87 | ALDH1A1 (0.67) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL7141925 | 0.87 | L3MBTL1 (0.67) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL7141927 | 0.87 | L3MBTL1 (0.67) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL2790159 | 0.85 | POLB (0.63) | L3MBTL1ALDH1A1POLBMAPTCACNA1B | |
| SCHEMBL2790157 | 0.85 | POLB (0.63) | L3MBTL1ALDH1A1POLBMAPTCACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024087650-A1 | PREPARATION METHOD FOR γ-HEPTALACTONE | 安徽华业香料股份有限公司 | 2024-05-02 | — | — | WO | claimed |
| CN-115466234-A | Novel preparation method of gamma-heptalactone | 安徽华业香料股份有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-114502667-A | Coating composition and laminate comprising coating | 株式会社东进世美肯 | 2022-05-13 | — | — | CN | claimed |
| WO-2021066628-A1 | COATING COMPOSITION AND LAMINATE COMPRISING COATING LAYER | 주식회사 동진쎄미켐 | 2021-04-08 | — | — | WO | claimed |
| JP-2003500486-A | — | — | 2003-01-07 | — | — | JP | claimed |
| EP-1185524-A2 | 3-HETEROARYLALKYL SUBSTITUTED GABA ANALOGS | WARNER-LAMBERT COMPANY (US) | 2002-03-13 | — | — | EP | claimed |
| WO-2000073296-A2 | 3-HETEROARYLALKYL SUBSTITUTED GABA ANALOGS | WARNER-LAMBERT COMPANY (US) | 2000-12-07 | — | — | WO | claimed |
| WO-2024087650-A1 | PREPARATION METHOD FOR γ-HEPTALACTONE | 安徽华业香料股份有限公司 | 2024-05-02 | — | — | WO | disclosed |
| WO-2024087650-A1 | PREPARATION METHOD FOR γ-HEPTALACTONE | 安徽华业香料股份有限公司 | 2024-05-02 | — | — | WO | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| WO-2023042894-A1 | FURANACRYLIC ACID ESTER POLYMER, PRODUCTION METHOD THEREFOR, AND POLYMERIZABLE MONOMER FOR USE IN PRODUCING SAID POLYMER AND PRODUCTION METHOD THEREFOR | 国立研究開発法人産業技術総合研究所 | 2023-03-23 | — | — | WO | disclosed |
| CN-115466234-A | Novel preparation method of gamma-heptalactone | 安徽华业香料股份有限公司 | 2022-12-13 | — | — | CN | disclosed |
| WO-2000073296-A2 | 3-HETEROARYLALKYL SUBSTITUTED GABA ANALOGS | WARNER-LAMBERT COMPANY (US) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000059880-A1 | CELL ADHESION-INHIBITING ANTIINFLAMMATORY AND IMMUNE-SUPPRESSIVE COMPOUNDS | ABBOTT LABORATORIES (US) | 2000-10-12 | — | — | WO | disclosed |
| EP-0046595-B1 | ACYLATED FURANYL AND THIENYL ACRYLIC ACIDS, PROCESS FOR THEIR PRODUCTION, AND PHARMACEUTICAL COMPOSITIONS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1984-10-24 | — | — | EP | disclosed |
| EP-0039989-B1 | PYRIMIDONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-08-29 | — | — | EP | disclosed |
| US-4388317-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-06-14 | — | — | US | disclosed |
| US-4335098-A | ANTILIPEMIC | MERRELL DOW PHARMACEUTICALS INC. (US) | 1982-06-15 | — | — | US | disclosed |
| EP-0039989-A1 | Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1981-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | L3MBTL1 4816/4885ALDH1A1 978/4885POLB 4295/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | L3MBTL1 4816/4885ALDH1A1 978/4885POLB 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.